De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT05903976
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico "G. Martino"
- Registry
-
NCT05903976
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT05903976. Randomized; no masking; primary purpose treatment. Start 2023-06-12 (actual); primary completion 2025-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS
- Acronym
- DESC-HBR
- Condition
- Dual Antiplatelet Therapy
- Condition
- Acute Coronary Syndrome
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- P2Y12 inhibitor de-escalation
- Lead sponsor
- Azienda Ospedaliera Universitaria Policlinico "G. Martino"
- Collaborator
- Giampiero Vizzari
- Collaborator
- Giorgio Quadri
- Collaborator
- Greca Zanda
- Collaborator
- Ferdinando Varbella
- Collaborator
- Gianluca Di Bella
- Collaborator
- Antonio Micari
Record details
- Record id
cardio:ct-nct05903976- Content hash
dd7036a7d88633c6d6a7687f7f25db2983f954f28a22b056aa6af584c1b1c526